Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 80.20
-0.70 (-0.87%)
Sep 24, 2026, 1:30 PM CST
Foresee Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 877.82 | 479.52 | 1,367 | 1,010 | 689.51 | 871.44 |
Short-Term Investments | 33.1 | - | - | 150 | - | 100 |
Trading Asset Securities | - | - | - | - | - | 297.47 |
Cash & Short-Term Investments | 910.92 | 479.52 | 1,367 | 1,160 | 689.51 | 1,269 |
Cash Growth | 5.04% | -64.93% | 17.90% | 68.19% | -45.66% | -21.76% |
Accounts Receivable | 55.63 | 43.48 | 32.33 | 65.91 | 16.27 | - |
Other Receivables | 16.14 | 17.28 | 26.55 | 22.18 | 10.13 | 5.73 |
Receivables | 71.77 | 60.76 | 58.88 | 88.09 | 26.4 | 5.73 |
Inventory | 163.85 | 144.71 | 183.87 | 126.8 | 176.41 | 24.88 |
Prepaid Expenses | 10.45 | 80.02 | 132.48 | 23.56 | 22.75 | 3.9 |
Other Current Assets | - | 220.7 | 75 | 192.5 | - | - |
Total Current Assets | 1,157 | 985.71 | 1,818 | 1,591 | 915.06 | 1,303 |
Property, Plant & Equipment | 190.25 | 207.16 | 217.62 | 135.01 | 142.39 | 91.19 |
Other Intangible Assets | 101.58 | 111.14 | 117.79 | 126.81 | 140.96 | 155.14 |
Long-Term Deferred Tax Assets | - | 1.25 | 1.31 | 1.23 | 1.22 | 1.1 |
Other Long-Term Assets | 172.11 | 5.13 | 4.9 | 7.76 | 104.39 | 90.58 |
Total Assets | 1,858 | 1,310 | 2,159 | 1,861 | 1,304 | 1,641 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 20.11 | 16.57 | 64.42 | 12.13 | 22.85 | - |
Accrued Expenses | 44.33 | 7.31 | 5.37 | 120.71 | 78.47 | 61.68 |
Short-Term Debt | - | 197 | 150 | 200 | - | - |
Current Portion of Long-Term Debt | - | - | 5 | - | - | - |
Current Portion of Leases | 14.16 | 14.23 | 12.41 | 15.14 | 15.52 | 10.2 |
Current Income Taxes Payable | 9.63 | 11.47 | 8.82 | 10.42 | 4.95 | - |
Current Unearned Revenue | - | - | 50.03 | 105.48 | 1.01 | 0.78 |
Other Current Liabilities | 40.54 | 39.71 | 97.16 | 6.96 | 6.38 | 1.79 |
Total Current Liabilities | 128.77 | 286.3 | 393.21 | 470.83 | 129.17 | 74.45 |
Long-Term Debt | 370.92 | - | 92.92 | - | - | - |
Long-Term Leases | 13.25 | 20.51 | - | 13.12 | 25.8 | 6.45 |
Long-Term Unearned Revenue | 72.62 | 72.62 | 72.62 | 131.67 | 237.15 | 239.17 |
Long-Term Deferred Tax Liabilities | - | 1.35 | 1.41 | 1.32 | 1.32 | 1.19 |
Total Liabilities | 585.57 | 380.78 | 560.15 | 616.93 | 393.43 | 321.26 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,575 | 1,575 | 1,548 | 1,358 | 1,182 | 1,179 |
Additional Paid-In Capital | 6,135 | 6,087 | 5,906 | 4,617 | 3,424 | 3,372 |
Retained Earnings | -6,411 | -6,694 | -5,811 | -4,730 | -3,693 | -3,221 |
Comprehensive Income & Other | -27.11 | -38.86 | -44.56 | -1.49 | -1.54 | -10.21 |
Shareholders' Equity | 1,273 | 929.61 | 1,599 | 1,245 | 910.58 | 1,320 |
Total Liabilities & Equity | 1,858 | 1,310 | 2,159 | 1,861 | 1,304 | 1,641 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 398.33 | 231.74 | 260.33 | 228.26 | 41.32 | 16.65 |
Net Cash (Debt) | 512.58 | 247.78 | 1,107 | 931.42 | 648.19 | 1,252 |
Net Cash Growth | -16.85% | -77.62% | 18.85% | 43.70% | -48.24% | -16.05% |
Net Cash Per Share | 3.25 | 1.60 | 8.06 | 7.32 | 5.49 | 10.67 |
Filing Date Shares Outstanding | 157.54 | 157.54 | 154.79 | 135.82 | 118.17 | 117.94 |
Total Common Shares Outstanding | 157.54 | 157.54 | 154.79 | 135.82 | 118.17 | 117.94 |
Working Capital | 1,028 | 699.41 | 1,424 | 1,120 | 785.89 | 1,229 |
Book Value Per Share | 8.08 | 5.90 | 10.33 | 9.16 | 7.71 | 11.19 |
Tangible Book Value | 1,171 | 818.47 | 1,481 | 1,118 | 769.62 | 1,165 |
Tangible Book Value Per Share | 7.43 | 5.20 | 9.57 | 8.23 | 6.51 | 9.88 |
Land | 123.07 | 123.07 | 123.07 | - | - | - |
Buildings | 9.96 | 9.96 | 9.96 | - | - | - |
Machinery | 227.92 | 227.88 | 226.59 | 209.45 | 171.58 | 136.94 |
Construction In Progress | - | - | - | 4.9 | 20.39 | 4.4 |
Leasehold Improvements | 30.44 | 30.44 | 30.44 | 30.44 | 7.71 | 7.71 |